TR200402446T4 - Servik aşınmanın tedavisi için sükralfatın kullanımı. - Google Patents

Servik aşınmanın tedavisi için sükralfatın kullanımı.

Info

Publication number
TR200402446T4
TR200402446T4 TR2004/02446T TR200402446T TR200402446T4 TR 200402446 T4 TR200402446 T4 TR 200402446T4 TR 2004/02446 T TR2004/02446 T TR 2004/02446T TR 200402446 T TR200402446 T TR 200402446T TR 200402446 T4 TR200402446 T4 TR 200402446T4
Authority
TR
Turkey
Prior art keywords
sucralfate
treatment
cervical erosion
sucrose octasulfate
affection
Prior art date
Application number
TR2004/02446T
Other languages
English (en)
Inventor
Gor� G�Anfranco
Guidi Aditeo
C/O Farmigea S.P.A. Alberto Federighi
C/O Farmigea S.P.A. Pietro Bianchini
C/O Farmigea S.P.A. Enrico Boldrini
Original Assignee
Farmigea S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmigea S.P.A. filed Critical Farmigea S.P.A.
Publication of TR200402446T4 publication Critical patent/TR200402446T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Bu bulus, servik asinma olarak bilinen üterin serviksin patolojik hastaliginin güncel intravajinal idaresi ile ön korumasi ve tedavisi için sükralfat olarak bilinen sakaroz oktasülfatin sulu bazik alüminyum tuzu veya kompleks yapmamis sülfat tuzunun (yani sakaroz oktasülfat) kullanimi ile ilgilidir.
TR2004/02446T 2001-05-03 2001-05-03 Servik aşınmanın tedavisi için sükralfatın kullanımı. TR200402446T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2001/000212 WO2002089818A1 (en) 2001-05-03 2001-05-03 Use of sucralfate for the treatment of cervical erosion

Publications (1)

Publication Number Publication Date
TR200402446T4 true TR200402446T4 (tr) 2004-12-21

Family

ID=11133654

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02446T TR200402446T4 (tr) 2001-05-03 2001-05-03 Servik aşınmanın tedavisi için sükralfatın kullanımı.

Country Status (13)

Country Link
US (1) US20040192640A1 (tr)
EP (1) EP1383512B1 (tr)
KR (1) KR100765683B1 (tr)
CN (1) CN1226037C (tr)
AT (1) ATE275405T1 (tr)
CA (1) CA2445506C (tr)
DE (1) DE60105452T2 (tr)
DK (1) DK1383512T3 (tr)
ES (1) ES2227189T3 (tr)
HK (1) HK1064607A1 (tr)
MX (1) MXPA03009838A (tr)
TR (1) TR200402446T4 (tr)
WO (1) WO2002089818A1 (tr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2522895T3 (es) 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华(广州)医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
DE602005008964D1 (de) * 2005-09-16 2008-09-25 Italfar Societa A Responsabili Wundheilende pharmazeutische Zusammensetzung enthaltend Sucralfat, Glycin, Aluminium Acetat und Vitamine
FR2927808B1 (fr) * 2008-02-26 2011-04-29 Fabre Pierre Dermo Cosmetique Gel de sucralfate sterilise
KR101016364B1 (ko) * 2009-06-24 2011-02-21 (주)아트웨어 건축설비용 타일형 엘이디 외벽마감재
FR2977798B1 (fr) * 2011-07-13 2016-07-29 Urgo Lab Utilisation de composes oligosaccharidiques pour la prevention et le traitement des cicatrices pathologiques
FR2977797B1 (fr) * 2011-07-13 2014-01-17 Urgo Lab Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures
CN106890321A (zh) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 一种用于预防和治疗***的方法
TWI623321B (zh) * 2015-12-18 2018-05-11 Talengen Institute Of Life Sciences Co Ltd Method for preventing and treating cervical erosion
US11007253B2 (en) 2015-12-18 2021-05-18 Talengen International Limited Method for preventing or treating radiation and chemical damage
CN107582806A (zh) * 2017-10-25 2018-01-16 桂林浩新科技服务有限公司 一种治疗***的药物组合物及用途
CN107596075A (zh) * 2017-10-25 2018-01-19 桂林浩新科技服务有限公司 一种治疗***的药物组合物配方及用途
CN107854471A (zh) * 2017-10-26 2018-03-30 郭裴哲 一种治疗***的药物制剂及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141511T1 (de) * 1991-04-15 1996-09-15 Applied Microbiology Inc Verwendung eines bakteriozin antibiotischen agenten zur herstellung eines arzneimittels zur behandlung von magenverstimmungen, die durch helicobacter pylori verursacht werden.
US5945446A (en) * 1997-02-10 1999-08-31 Laubc Biochemicals, Corporation Process for preparing synthetic soil-extract materials and medicaments based thereon
JPH1143333A (ja) * 1997-07-22 1999-02-16 Minolta Co Ltd 金型保護膜
AU2798299A (en) * 1998-02-27 1999-09-15 Althexis Company, The Therapeutic and prophylactic uses of negatively charged substituted disaccharides

Also Published As

Publication number Publication date
KR20040018365A (ko) 2004-03-03
DE60105452D1 (de) 2004-10-14
ES2227189T3 (es) 2005-04-01
DK1383512T3 (da) 2004-11-15
CN1226037C (zh) 2005-11-09
HK1064607A1 (en) 2005-02-04
CA2445506C (en) 2009-04-14
US20040192640A1 (en) 2004-09-30
CN1505518A (zh) 2004-06-16
EP1383512B1 (en) 2004-09-08
MXPA03009838A (es) 2004-09-13
CA2445506A1 (en) 2002-11-14
DE60105452T2 (de) 2005-10-13
ATE275405T1 (de) 2004-09-15
EP1383512A1 (en) 2004-01-28
KR100765683B1 (ko) 2007-10-11
WO2002089818A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
TR200402446T4 (tr) Servik aşınmanın tedavisi için sükralfatın kullanımı.
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
RS41904A (en) Macrolides
NO20023884L (no) Fremgangsmåte for behandling eller profylakse av flavivirus- infeksjoner ved å anvende nukleosidanaloger
LU92595I2 (fr) Siméprévir, ou l'un de ses sels pharmaceutiquementacceptables, incluant siméprévir sodium
EA200601591A1 (ru) Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
PT956858E (pt) Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
SE0102315D0 (sv) Compounds
HK1102221A1 (en) Vaginally administered anti-dysrhythmic agents for treating uterine dysrhythimia
DE60123277D1 (de) Makrolidantibiotika
GB0112348D0 (en) Compounds
NO20065662L (no) Esterlinkede makrolider nyttige for behandlingen av mikrobielle infeksjoner
HUP0501111A2 (en) Treatment of severe pneumonia by administration of tissue factor pathway inhibitor
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
DE60305053D1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
HUP0402080A2 (hu) Kannabinoid receptor agonisták alkalmazása gastrooesophagealis reflux betegség kezelésére szolgáló gyógyszer előállítására
NO20020926L (no) Sf¶riske agglomerater av telitromycin, fremgangsmåte ved deres fremstilling og deres anvendelse for frestilling avfarmasöytiske former
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
WO2003007923A3 (de) Verwendung von trifluoracetylalkyl-substituierte phenyl-, phenol- und benzoylderivate in der behandlung und/oder prophylaxe von obesitas und deren begleit- und/oder folgeerkrankungen
EA200100876A3 (ru) Фармацевтическая композиция для предупреждения или лечения заболевания, связанного с избыточным продуцированием il-12
GR20010100390A (el) Χρηση του diclofenac h αποδεκτων αλατων αυτου για την αντιμετωπιση των εγκαυματων.
PT1212049E (pt) Utilizacao do tianfenicol para o tratamento de infeccoes por chlamydia pneumoniae
ITRE20010012V0 (it) Pinzetta per stringere tra loro due tubi coassiali per uso medicale.
PT1383512E (pt) Utilizacao de sucralfato para o tratamento de erosao cervical
IT247866Y1 (it) Mascherina per la profilassi di malattie infettive che si trasmettonoper via sessuale,in particolare dell'aids